Technology | September 25, 2014

Mallinckrodt Begins U.S. Launch Of OptiSync Contrast Data Management System

System aims to enable more effective use and management of radiology data

Mallinckrodt U.S. Launch OptiSync Contrast Data Management System

September 25, 2014 — Mallinckrodt announced the U.S. launch of the OptiSync data management system as a new technology in its Global Medical Imaging segment. The OptiSync system is designed to help healthcare professionals efficiently collect and analyze radiology data from when a patient undergoes a contrast media-enhanced computed tomography (CT) diagnostic imaging procedure.

The OptiSync system is used with the OptiVantage dual-head CT contrast delivery system, and allows users to verify and log patient and pharmaceutical information with the scan of a barcode. As injection data is collected, the OptiSync system transmits patient, drug, dose and administration information to HL7-based healthcare systems and automates patient record updates. By assembling a database that includes contrast media usage, spend, workflow and benchmarking across all users, scanners and facilities, the OptiSync system can help users identify areas where they can reduce errors, increase productivity or improve efficiency.

“The OptiSync data management system was created with patients and customers in mind,” said Dan Brague, Mallinckrodt vice president and general manager, Imaging – North America. “We are pleased to launch this important tool to help empower decision-making in radiology departments with easier data collection and more efficient contrast media management and usage.”

For more information: OptiSync.com, www.mallinckrodt.com


Related Content

News | Contrast Media

August 17, 2023 — University of Missouri School of Medicine neurologist Adnan Qureshi, MD recently led a study that ...

Home August 17, 2023
Home
News | Contrast Media

July 3, 2023 — According to an accepted manuscript published in ARRS’ own American Journal of Roentgenology (AJR) ...

Home July 03, 2023
Home
News | Contrast Media

May 11, 2021 — The American Institute of Ultrasound in Medicine (AIUM) and the American Society of Echocardiography (ASE ...

Home May 11, 2021
Home
Technology | Contrast Media

July 15, 2019 — The U.S. Food and Drug Administration (FDA) has approved Gadavist injection for use in cardiac magnetic ...

Home July 15, 2019
Home
Videos | Contrast Media

Sharon Mulvagh, M.D., FASE, FACC, FRCPC, professor of medicine, division of cardiology, Dalhousie University, Halifax ...

Home June 28, 2019
Home
Feature | Contrast Media | Dave Fornell, Editor

Iodine-based contrast agents used in computed tomography (CT) and catheter-based angiography have been implicated as a ...

Home May 31, 2019
Home
News | Contrast Media

May 9, 2019 — Osprey Medical announced the launch of DyeMINISH, a global patient registry to evaluate the ongoing safety ...

Home May 09, 2019
Home
News | Contrast Media

November 30, 2018 — VigiLanz and Cincinnati Children’s Hospital Medical Center recently announced a collaboration that ...

Home November 30, 2018
Home
News | Contrast Media

In February 2018, a workshop was held at the National Institutes of Health (NIH) in Bethesda, Maryland, to explore ...

Home September 12, 2018
Home
News | Contrast Media

January 19, 2018 — Ligand Pharmaceuticals Inc. announced initiation of a program to develop contrast agents with reduced ...

Home January 19, 2018
Home
Subscribe Now